Skip to search formSkip to main contentSkip to account menu

nafamostat mesilate

Known as: Nafamostat Dimethanesulfonate, Nafamostat Mesylate, 6-Amidino2-naphthyl 4-guanidinobenzoate 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

FUT 175
nafamostat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Inhibition of intraluminal pancreatic enzymes with nafamostat mesilate improves clinical outcomes after hemorrhagic shock in swine.
BACKGROUND Recent studies suggest that intraluminal pancreatic enzymes play a major role in the initiation of the inflammatory… 
2009
2009
Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.
PURPOSE Gemcitabine is currently the standard first-line chemotherapeutic agent for pancreatic cancer. However, chemoresistance… 
2009
2009
A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.
BACKGROUND The primary end points of this study were to determine the dose-limiting toxic effects (DLTs), maximum tolerated dose… 
2004
2004
Detection of Specific IgE Antibodies to Nafamostat Mesilate as an Indication of Possible Adverse Effects of Leukocytapheresis using Nafamostat Mesilate as Anticoagulant
Abstract: The aim was to determine whether adverse effects of leukocytapheresis (LCAP) are related to nafamostat mesilate (NM) as… 
2003
2003
Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient.
We report on the management of a 36-year-old hemodialysis patient with heparin-induced thrombocytopenia (HIT, type II) and clot… 
2000
2000
Anticoagulation during use of a left ventricular assist device.
Thirty-six mongrel dogs underwent 24hr left ventricular assist. The VAD was placed between the left atrium and the descending… 
1995
1995
Hyperkalemia due to nafamostat mesylate.
To the Editor: Nafamostat mesylate (6-amidino-2-naphthyl p-guanidinobenzoate, dimethanesulfonate; molecular weight, 540) is a… 
1994
1994
Mechanisms of the hyperkalaemia caused by nafamostat mesilate: effects of its two metabolites on Na+ and K+ transport properties in the rabbit cortical collecting duct
1 The present experiments were undertaken to determine the mechanism(s) of hyperkalaemia caused by nafamostat mesilate (NM), a… 
1993
1993
Effect of nafamostat mesilate on Na+ and K+ transport properties in the rabbit cortical collecting duct
1 To determine the mechanism(s) of hyperkalemia caused by nafamostat mesilate (NM), a serine‐protease inhibitor, we investigated… 
1989
1989
The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat
SummaryWe examined the ability of a highly potent synthetic protease inhibitor, nafamostat mesilate (FUT-175), to protect the rat… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)